Journal article
The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy
Abstract
PURPOSE: To explore how follicle-stimulating hormone (FSH) may contribute to cardiovascular, metabolic, skeletal, and cognitive events in men treated for prostate cancer, with various forms of androgen deprivation therapy (ADT).
MATERIALS AND METHODS: A colloquium of prostate cancer experts was convened in May 2015, to discuss the role of FSH in the development of unwanted effects associated with ADT. Subsequently, a literature review (Medline, …
Authors
Crawford ED; Schally AV; Pinthus JH; Block NL; Rick FG; Garnick MB; Eckel RH; Keane TE; Shore ND; Dahdal DN
Journal
Urologic Oncology Seminars and Original Investigations, Vol. 35, No. 5, pp. 183–191
Publisher
Elsevier
Publication Date
5 2017
DOI
10.1016/j.urolonc.2017.01.025
ISSN
1078-1439